Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer

Darren Cowzer(Memorial Sloan Kettering Cancer Center), James J. Harding(Memorial Sloan Kettering Cancer Center), Randy Yeh(Presbyterian Hospital), Henry Walch(Memorial Sloan Kettering Cancer Center), Rohit Thummalapalli(Memorial Sloan Kettering Cancer Center), Danny N. Khalil(Memorial Sloan Kettering Cancer Center), Walid K. Chatila(Memorial Sloan Kettering Cancer Center), Aruj Dhyani(Memorial Sloan Kettering Cancer Center), Sepideh Gholami(University of California, Davis), Madison Darmofal(Memorial Sloan Kettering Cancer Center), Andrea Cercek(Memorial Sloan Kettering Cancer Center), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Wungki Park(University of Miami), Michael F. Berger(Memorial Sloan Kettering Cancer Center), William R. Jarnagin(Memorial Sloan Kettering Cancer Center), Joseph P. Erinjeri(Memorial Sloan Kettering Cancer Center), Paul Shin(Saint John's Health Center), Mithat Gönen(Memorial Sloan Kettering Cancer Center), Richard Kinh Gian(Memorial Sloan Kettering Cancer Center), Kenneth Seier(Memorial Sloan Kettering Cancer Center), Amin Yaqubie(Memorial Sloan Kettering Cancer Center), Eileen M. O’Reilly(Memorial Sloan Kettering Cancer Center), Ghassan K. Abou‐Alfa(Memorial Sloan Kettering Cancer Center), Jinru Shia(Memorial Sloan Kettering Cancer Center), Olca Baştürk(Memorial Sloan Kettering Cancer Center), Alison M. Schram(Memorial Sloan Kettering Cancer Center), Alice C. Wei(Université Paris Cité), David B. Solit(Memorial Sloan Kettering Cancer Center), Imane El Dika(Memorial Sloan Kettering Cancer Center)
JCO Precision Oncology
September 1, 2025
Cited by 3


Related Papers